Condition

Seizures

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting2
Common interventions17
Lead sponsors shown14
Advertisement

Clinical trials

15 shown
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain MetastasesNCT07130786 · 2025-12-23
RECRUITING
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeNCT07234695 · 2025-12-22
RECRUITING
Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With EclampsiaNCT06997575 · 2025-05-13
COMPLETED
Checklists Resuscitation Emergency DepartmentNCT05649891 · 2023-09-01
UNKNOWN
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep SedationNCT06067750 · 2023-06-27
COMPLETED
Study on Optic Nerve Sheath Diameter Measurements in Prolonged Pediatric SeizuresNCT06451289 · 2020-09-01
COMPLETED
Advancing Understanding of Transportation OptionsNCT04141891 · 2019-12-12
COMPLETED
Neurology Inpatient Clinical Education TrialNCT03826056 · 2019-02-01
COMPLETED
Outcomes Mandate National Integration With Cannabis as MedicineNCT03944447 · 2018-12-01
UNKNOWN
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)NCT02544750 · 2016-08-31
COMPLETED
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)NCT02544763 · 2016-04-06
COMPLETED
Biomarkers In Seizure To Predict Recurrence and Severe OutcomesNCT01774500 · 2013-01-01
COMPLETED
Seizure Activity in Alzheimer's DiseaseNCT01554683 · 2012-02-01
COMPLETED
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareNCT01431326 · 2011-11-01
COMPLETED
Neuropsychological Evaluation of Psychiatric and Neurological PatientsNCT00001192 · 1983-10-18
COMPLETED

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Trial status mix

COMPLETED11
RECRUITING2
UNKNOWN2

Phase mix

NA4
PHASE33
PHASE22
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.